COLIJECT
COLISTINE
About this veterinary medicine
COLIJECT is a veterinary medicine in the form of solution injectable containing colistine. It is marketed by TIMPHARM. It holds a marketing authorisation in Tunisia under number 183.1227.12.
Characteristics
- Form
- Solution injectable
- Strength
- 50 MUI
- Presentation
- Flacon de 100 ml
- Route of administration
- Injectable route
- Laboratory
- TIMPHARM
- Country
- TUNISIE
- Therapeutic class
- ANTIBIOTIQUES SEULS
Regulatory status — Tunisie
🟢 Marketing authorisation in force
Authorisation no. : 183.1227.12 — Authorisation date : 24/05/2012
⚠️ Regulatory alerts
No alert reported.
🔴 Batch recalls
No batch currently reported as recalled.
📦 Availability in Tunisia
Reported by TunisieVet veterinarians.
No availability information yet.
🔒 Availability reporting is reserved for signed-in veterinarians.
Sources
- dpm verified on 30/09/2026
- pct verified on 30/09/2026
Last synchronisation : 30/09/2026
Report availability
Sign in to your veterinarian account to report availability.
Log InOnly veterinarians can report availability.
TunisieVet in your pocket 📱🐾 Access your veterinary services wherever you are. [ Download the app ]
Learn more